Close

LOGIN

Remember me
Not a member?
or
Connect using:
Why BS?

We encourage visitors to register on Business Standard. Registering on the site is absolutely Free and offers you the following benefits.

Free Daily E-newsletter

Breaking News Alerts in your Inbox

Post Comments and Share your Feedback

Your Personal Business Standard Page

Free Portfolio of Stocks, Equity and Commodities Derivatives

Access Premium Services

Receive Selective Offers from our Third Party Premium Advertisers

Get Invited to Business Standard Events

Close

FORGOT PASSWORD?

Not a member?

Letters: No takers for R&D

Private players should wake up to the fact that research activities are the key to global opportunities and growth

Related News

This refers to the Q&A with J G Kulkarni "R&D and innovation find little place in Indian industry" (October 8). India is way behind countries like China, South Korea and Mexico in the field of research and development (R&D). To start with, academics and professionals in our country hardly show any interest in R&D. The shortage of people with doctorate degrees only adds to this problem. As a result, most research centres in India are running without talented research scholars.

It is only the public sector that is involved in R&D activities in India. But we need private participation to enhance competition in the field. Private players should wake up to the fact that research activities are the key to global opportunities and growth. For example, Glenmark has emerged as one of the well-known, research-based pharmaceuticals in India and its revenue has risen to $2.6 billion. Finally, a good amount of money should be earmarked for R&D activities because limited resources often come in the way of growth of research centres.

P Senthil Saravana Durai Mumbai

Letters can be mailed, faxed or e-mailed to:
The Editor, Business Standard
Nehru House, 4 Bahadur Shah Zafar Marg
New Delhi 110 002
Fax: (011) 23720201
E-mail: letters@bsmail.in
All letters must have a postal address and telephone number

Read more on:   
|
|

Read More

Letters: A common investor's woes

This refers to the edit “Trial and error” (October 26). Rajat Gupta merely helped a friend with insider tips and asked nothing in return. He is now ...

Back to Top

Quick Links

Have Your Say Rss icon




Image4

What punishment would you prescribe for sexual harassment at the workplace?

Financial X-Ray Rss icon

L&T: Q4 numbers disappoint, but valuations don't

Company has historically traded at 28% premium to the Sensex but now valuations on a par with the benchmark

Colgate: P&G's toothpaste foray will raise competitive pressures

While analysts expect relatively lesser impact for Colgate, high stock valuations will cap further upsides

Back to Top